Remarkably, silencing of MECOM or ETS2 led to the inhibition of both monolayer colony-formation (Fig. 5A) and sphere-formation capacity (Fig. 5B) of CRC cells, while MECOM but not ETS2 was required for maintaining the migration potential of CRC cells (Fig. 5C). The gene discussed is ETS2; the disease is colorectal carcinoma.